Bo‐Wei Wang

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

China Medical University

National Yang Ming University Hospital

National Yang Ming Chiao Tung University

Asia University

Bo‐Wei Wang is an author at The University of Texas MD Anderson Cancer Center specializing in signal transduction, tyrosine kinase inhibitors, and oncology.

ORCID

Publications per year

2020–2021

Publications

Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC

Fang‐Ju Cheng, Chia‐Hung Chen, Wen‐Chen Tsai et al. · Oncogene · 2020 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17

PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs

Chia‐Hung Chen, Bo‐Wei Wang, Yu-Chun Hsiao et al. · Oncogene · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2